Skip to main content
. 2016 Feb 2;20(2):127–133. doi: 10.1016/j.bjid.2015.11.011

Table 2.

Prevalence of virulence genes in 510 clinical Enterococcus spp. (370 E. faecalis and 140 E. faecium) isolates according to the site of infection.

Gene Number (%) of isolates with the respective gene
Urine Wounds Genital tracta Blood Othersb Total
(nFL = 176)
(nFM = 80)
(n = 256)
(nFL = 96)
(nFM = 42)
(n = 138)
(nFL = 70)
(nFM = 4)
(n = 74)
(nFL = 18)
(nFM = 8)
(n = 26)
(nFL = 10)
(nFM = 6)
(n = 16)
(nFL = 370)
(nFM = 140)
(n = 510)
esp-FL 114 (64.8) 58 (60.4) 38 (54.3) 6 (33.3) 4 (40.0) 220 (59.5)
esp-FM 2 (2.5) 4 (9.5) 0 (0) 0 (0) 0 (0) 6 (22.8)
esp-FL + esp-FM 116 (45.3) 62 (44.9) 38 (51.4) 6 (23.1) 4 (25.0) 226 (44.3)
agg 76 (43.2) 42 (43.8) 40 (57.1) 4 (22.2) 2 (20.0) 164 (44.3)
asa1 16 (20.0) 12 (28.6) 4 (100) 0 (0) 0 (0) 32 (22.8)
agg + asa1 92 (36.0) 54 (39.1) 44 (59.5) 4 (15.4) 2 (12.5) 196 (38.5)
ace 114 (64.8) 52 (54.2) 38 (54.3) 14 (77.8) 8 (80.0) 226 (61.1)
acm 56 (70.0) 30 (71.4) 2 (50.0) 8 (100) 6 (100) 102 (72.8)
ace + acm 170 (66.4) 82 (59.4) 40 (54.1) 22 (84.6) 14 (87.5) 328 (64.3)
efaA-FL 166 (94.3) 70 (72.9) 58 (82.9) 12 (66.7) 8 (80.0) 314 (84.9)
efaA-FM 74 (92.5) 36 (85.7) 4 (100) 4 (50.0) 6 (100) 124 (88.5)
efaA-FL + efaA-FM 240 (93.8) 106 (76.8) 62 (83.8) 16 (61.5) 14 (87.6) 438 (85.9)
eep-FL 174 (98.9) 90 (93.8) 66 (94.3) 16 (88.9) 8 (80.0) 354 (95.7)
eep-FM N/A N/A N/A N/A N/A N/A
gelE-FL 146 (83.0) 78 (81.3) 58 (82.9) 14 (77.8) 8 (80.0) 304 (82.2)
gelE-FM 12 (15.0) 10 (23.8) 2 (50.0) 0 (0) 0 (0) 24 (17.1)
gelE-FL + gelE-FM 158 (61.7) 88 (63.7) 60 (81.1) 14 (53.8) 8 (50.0) 328 (64.3)
hyl-FL 48 (27.3) 22 (22.9) 20 (28.6) 4 (22.2) 0 (0) 94 (25.3)
hyl-FM 22 (27.5) 8 (19.0) 2 (50) 2 (25.0) 0 (0) 34 (24.2)
hyl-FL + hyl-FM 70 (27.3) 30 (21.7) 22 (29.7) 6 (23.1) 0 (0) 128 (25.1)
cylA-FL 110 (62.5) 62 (64.6) 54 (77.1) 8 (44.4) 6 (60.0) 240 (64.9)
cylA-FM N/A N/A N/A N/A N/A N/A

FL, E. faecalis; FM, E. faecium; N/A, not applicable for E. faecium. esp, gene for enterococcal surface protein (adhesin) for both species; agg, E. faecalis aggregation substance involved in adherence to mammalian cells and conjugation; asa1, E. faecium aggregation substance involved in adherence to mammalian cells and conjugation; ace, E. faecalis Ace collagen-binding protein (adhesin); acm, E. faecium Acm collagen-binding protein (adhesin); efaA, cell wall adhesin expressed in patient serum (endocarditis-specific antigen A) for both species; eep (enhanced expression of pheromone), membrane protein of E. faecalis; gelE, extracellular metalloendopeptidase (gelatinase) for both species; hyl, hyaluronidase for both species; cylA, activation of cytolysin (hemolysin/class I. bacteriocin) of E. faecalis.

a

Genital tract specimens – sperm, urethral, vaginal and cervical samples.

b

others – peritoneal fluid (n = 6), bile (n = 2) and lower respiratory tract samples (n = 8).